City
Epaper

India’s 1st robotic system SSI Mantra gets CDSCO nod for telesurgery & teleproctoring

By IANS | Updated: December 9, 2024 17:40 IST

New Delhi, Dec 9 The Central Drugs Standard Control Organization (CDSCO) has granted regulatory approval to SSI Mantra, ...

Open in App

New Delhi, Dec 9 The Central Drugs Standard Control Organization (CDSCO) has granted regulatory approval to SSI Mantra, the first made-in-India surgical robotic system, for telesurgery and teleproctoring, signifying a monumental leap in surgical robotics, the company said on Monday.

Developed by Gurugram-based SS Innovations, the system aims to decentralise and democratise access to surgical expertise. It also addresses critical gaps in healthcare, particularly in remote areas, where access to specialised medical care has often been a challenge.

“Telesurgery and teleproctoring have been a dream in the making for over four decades, and today, it has finally come to life. With the technology and bandwidth available now, we can truly decentralise and democratise surgical expertise, reaching patients and surgeons in the most remote parts of India and the world,” said Dr. Sudhir Srivastava, SS Innovations Founder, Chairman, and CEO.

“This innovation is a game-changer, especially for our country, where much of the population lives in smaller towns and rural areas.

Recently, SS Innovations launched SSI Mantra 3 -- the next generation and the most advanced version of the Mantra surgical robot system, which also achieved a historic feat by completing India's first human trial in telesurgery.

The surgery -- a robotic cholecystectomy -- took place between the World Laparoscopy Hospital and the SSI Headquarters over a distance of 5 km, using the seamless connectivity of Airtel's fiber optic network with no perceptible delay. Cholecystectomy is a surgical procedure to remove the gallbladder.

SSI Mantra 3 is highly advanced and is designed to enhance surgical precision, efficiency, and patient outcomes by integrating the latest advancements in robotic surgery.

In October, SS Innovations announced the completion of over 2,000 surgeries, of which 124 were cardiac cases. The robotic system ensured zero mortality and no device-related adverse events.

The system has also been used in 789 general surgeries, 621 urology surgeries, and 269 gynecology procedures, demonstrating its versatility across multiple specialties.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

BusinessBusiness Optimism Index Edges Higher in Q2 2025 Amid Domestic Demand Recovery

Other SportsBeau Webster all set to make Warwickshire debut ahead of WTC final

BusinessDLF Emporio Presents 'The Designers' Collective'

BusinessHero Motocorp year on year sales declines by 42.76 per cent in April'25

NationalThings won't work like this: Delhi CM slams officials during visit to waterlogged Majnu Ka Tila

Health Realted Stories

HealthHidden virus found common in germs that cause pneumonia: Study

HealthSmriti Irani opens up about her ‘companion of thoughts’

HealthUS launches next-generation universal vaccine platform for pandemic-prone viruses

HealthSocial pension: Tripura govt sets up new help desk for cancer patients

HealthTN school reopening decision will depend on heatwave conditions: Minister